Loading…

S100A11 is a potential prognostic marker for clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is one of few cancers with rising incidence in North America. The prognosis of ccRCC is variable and difficult to predict. Stratification of patients according to disease aggressiveness can significantly improve patient management. We investigated the expressi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & experimental metastasis 2016-01, Vol.33 (1), p.63-71
Main Authors: Gabril, Manal, Girgis, Hala, Scorilas, Andreas, Rotondo, Fabio, Wala, Samantha, Bjarnason, Georg A., Ding, Qiang, Evans, Andrew, Tawedrous, Eriny, Pasic, Maria, Finelli, Antonio, Al-Haddad, Sahar, Yousef, George M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clear cell renal cell carcinoma (ccRCC) is one of few cancers with rising incidence in North America. The prognosis of ccRCC is variable and difficult to predict. Stratification of patients according to disease aggressiveness can significantly improve patient management. We investigated the expression of the S100A11 protein in 385 patients with primary ccRCC using immunohistochemistry on tissue microarrays. We compared its expression with clinicopathologic parameters and patients’ survival. We also validated our results at the mRNA level on an independent set from The Cancer Genome Atlas. As a dichotomous variable (low vs. high expression), there was a significant association between S100A11 expression and tumor grade, with higher expression associated with higher tumor grades (p 
ISSN:0262-0898
1573-7276
DOI:10.1007/s10585-015-9758-6